← Back to search

Protein Structures and Oligomeric States

Enter a protein name, UniProt accession or PDB ID. Name searches ask you to confirm the protein identity before related structures are queried.

Current Protein Identity：Q2EHL9 New Search
2PDB entries
4Biological assembly
18chain/assembly records
UNP PDB Protein and construct Assembly Composition class Protein state Molecular copy count PDB declaration Consistency status
Q2EHL9 4dk0 Putative MacA Author chain A Reference sequence 30–394 1 Protein homooligomer Homooligomer Protein 12 dodecameric （12） Consistent with protein count
Q2EHL9 4dk0 Putative MacA Author chain A Reference sequence 30–394 2 Protein homooligomer Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain A Reference sequence 30–88 1 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain A Reference sequence 181–394 1 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain B Reference sequence 30–88 1 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain B Reference sequence 181–394 1 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain C Reference sequence 30–88 1 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain C Reference sequence 181–394 1 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain D Reference sequence 30–88 1 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain D Reference sequence 181–394 1 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain A Reference sequence 30–88 2 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain A Reference sequence 181–394 2 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain B Reference sequence 30–88 2 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain B Reference sequence 181–394 2 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain C Reference sequence 30–88 2 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain C Reference sequence 181–394 2 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain D Reference sequence 30–88 2 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count
Q2EHL9 4dk1 Putative MacA, Multidrug resistance protein mexA Author chain D Reference sequence 181–394 2 Insufficient information Homooligomer Protein 6 hexameric （6） Consistent with protein count

“Homomeric versus heteromeric classification follows protein identity; different constructs of the same UniProt entry still require comparison of reference-sequence ranges, mutations and missing segments. Assemblies marked for review remain visible but are not included in the highest-confidence candidate set.